Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on June 16, 2008

Circulation. 2008
Published online before print June 16, 2008, doi: 10.1161/CIRCULATIONAHA.107.726869
A more recent version of this article appeared on July 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
118/1/66    most recent
CIRCULATIONAHA.107.726869v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Rij, A. M.
Right arrow Articles by Packer, S. G.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Rij, A. M.
Right arrow Articles by Packer, S. G.K.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*TEFLON
Medline Plus Health Information
*Varicose Veins
Related Collections
Right arrow Secondary prevention
Right arrow Angiogenesis
Right arrow CV surgery: other
Right arrow Other Vascular biology
Right arrowRelated Article

Submitted on July 10, 2007
Accepted on April 14, 2008

Mechanical Inhibition of Angiogenesis at the Saphenofemoral Junction in the Surgical Treatment of Varicose Veins. Early Results of a Blinded Randomized Controlled Trial

André M. van Rij MD, FRACS*, Gregory T. Jones PhD, B. Geraldine Hill BSc(Hon), Mohammad Amer MB, ChB, Ian A. Thomson MB, ChB, FRACS, Ross A. Pettigrew MB, ChB, FRACS, and Stephen G.K. Packer MB, ChB, FRACS

From the Department of Surgery, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

* To whom correspondence should be addressed. E-mail: andre.vanrij{at}stonebow.otago.ac.nz.

Background—Saphenofemoral junction (SFJ) ligation has been a major component of surgical intervention for varicose veins; however, recurrence occurs in as many as 40%. Neovascularization with reconnection of the venous channels at the transected SFJ has been identified as the major cause of this recurrence. This randomized controlled study sought to evaluate mechanical suppression of neovascularization at the SFJ, with the use of a synthetic patch, to prevent recurrence after ligation surgery.

Methods and Results—A total of 389 limbs (from 292 patients) were randomized into either control (SFJ ligation surgery) or patch (SFJ ligation with polytetrafluoroethylene patch of the transected SFJ) groups. All patients underwent clinical assessment, duplex imaging, and air plethysmography studies preoperatively and at 1, 6, 12, and 36 months postoperatively. The patch consistently halved the recurrence rate to 3 years postoperatively in all clinical subgroups. In those patched SFJs that still developed recurrence, evidence of neovascularization circumventing the polytetrafluoroethylene patch was observed by both ultrasound and histology.

Conclusions—This study demonstrates that use of a polytetrafluoroethylene patch is an effective mechanical suppressant of neovasculogenesis at the SFJ and can be safely used as a strategy to improve long-term outcome of varicose vein surgery.


Key words: angiogenesis • follow-up studies • surgery • varicose veins • veins


Related Article:

Clinical Summaries
Circulation 2008 118: 1-2. [Extract] [Full Text]